Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Primary Central Nervous System Neoplasm”

141 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 141 results

Testing effectiveness (Phase 2)Study completedNCT02116777
What this trial is testing

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

Who this might be right for
Adult Solid NeoplasmChildhood Solid NeoplasmRecurrent Childhood Central Nervous System Neoplasm+3 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Looking for participantsNCT05278208
What this trial is testing

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Who this might be right for
High Grade GliomaMeningiomaEmbryonal Tumor+10 more
Nationwide Children's Hospital 65
Large-scale testing (Phase 3)UnknownNCT00020865
What this trial is testing

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionLeukemia+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02542514
What this trial is testing

Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma

Who this might be right for
Primary Central Nervous LymphomaIntraocular Lymphoma
The Lymphoma Academic Research Organisation 52
Early research (Phase 1)Study completedNCT01722305
What this trial is testing

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Who this might be right for
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt LymphomaCentral Nervous System LymphomaIntraocular Lymphoma+3 more
Mayo Clinic 29
Not applicableStudy completedNCT00376922
What this trial is testing

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Wake Forest University Health Sciences 65
Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100
Testing effectiveness (Phase 2)Study completedNCT00006225
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

Who this might be right for
Breast CancerLeukemiaLymphoma+2 more
Northwestern University
Early research (Phase 1)Study completedNCT00003993
What this trial is testing

Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institute on Aging (NIA) 24
Not applicableWithdrawnNCT00900120
What this trial is testing

Collecting and Storing Blood Samples From Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Study completedNCT01528046
What this trial is testing

Metformin in Children With Relapsed or Refractory Solid Tumors

Who this might be right for
Solid TumorsPrimary Brain Tumors
H. Lee Moffitt Cancer Center and Research Institute 26
Early research (Phase 1)Study completedNCT02415153
What this trial is testing

Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

Who this might be right for
Neurofibromatosis Type 1Recurrent Childhood Brain Stem GliomaRecurrent Childhood Visual Pathway Glioma+2 more
National Cancer Institute (NCI) 29
Not applicableLooking for participantsNCT05469373
What this trial is testing

ESIS in Pediatric DRE

Who this might be right for
Epilepsy
Sarah Katie Ihnen 86
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07680322
What this trial is testing

The Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy

Who this might be right for
Tuberous Sclerosis ComplexEpilepsy
Aeovian Pharmaceuticals, Inc. 42
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT02301364
What this trial is testing

Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Who this might be right for
LymphomaPrimary Central Nervous System LymphomaRecurrent/Refractory Secondary Central Nervous System Lymphoma
Memorial Sloan Kettering Cancer Center 4
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Looking for participantsNCT06712810
What this trial is testing

Q702 for the Treatment of Patients With Hematologic Malignancies

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmHistiocytic SarcomaMalignant Histiocytosis+34 more
Mayo Clinic 46
Early research (Phase 1)Active Not RecruitingNCT04608487
What this trial is testing

Axi-cel in CNS Lymphoma

Who this might be right for
LymphomaLymphoma Cns
Dana-Farber Cancer Institute 18
Early research (Phase 1)Study completedNCT00326664
What this trial is testing

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Cerebral Anaplastic Astrocytoma+18 more
National Cancer Institute (NCI) 55
Next Page